Article

Evaluation of Serum Fibronectin Levels and Fibronectin Gene Polymorphism in Patients Receiving Intravesical BCG Therapy for NonMuscle Invasive Bladder Cancer

2024-07-03

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Bladder cancer remains a significant health concern, prompting research into novel biomarkers and treatment strategies. In this study, we aimed to investigate the serum fibronectin levels and gene polymorphisms between patients with NMIBC receiving intravesical BCG treatment and the control group. <bold>Methods: </bold>Between June 2022 and December 2022, data o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 094294f9-5d6d-58f6-9692-6d24aade2e5a
DOI: 10.21203/rs.3.rs-4573841/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Evaluation of Serum Fibronectin Levels and Fibronectin Gene Polymorphism in Patients Receiving Intravesical BCG Therapy for NonMuscle Invasive Bladder CancerDOI 10.21203/rs.3.rs-4573841/v1Read

Uromonitor®: Clinical Validation and Performance Assessment of a Urinary Biomarker for Recurrence Surveillance in Non-Muscle Invasive Bladder Cancer PatientsSemantic proximity Read

Novel Gene expression-based Risk Stratification tool predicts recurrence in Non-muscle invasive Bladder cancerSemantic proximity Read

[Molecular classification of bladder cancer in 2021].Semantic proximity Read

Diagnostic Test Accuracy of Commercially Available Tests for The Recurrence of Bladder Cancer: A Systematic Review and Meta-AnalysisSemantic proximity Read

Prognostic Factors of Non-Muscle Invasive Bladder Cancer: A Study Based on Next-generation SequencingSemantic proximity Read

The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer in a genome-wide association study.Semantic proximity Read

A Muscle-Invasive Bladder Cancer Patient With High Tumor Mutational Burden and RB1 Mutation Achieved Bladder Preservation Following Chemotherapy Combined With Immunotherapy: A Case Report.Semantic proximity Read

Current look at the most promising proteomic and glycomic biomarkers of bladder cancer.Semantic proximity Read

Genome-wide association study of genetic variations associated with treatment failure after intravesical bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer.Semantic proximity Read

The Roles of miRNAs in Predicting Bladder Cancer Recurrence and Resistance to TreatmentSemantic proximity Read

Urinary DNA Methylation Test for Bladder Cancer DiagnosisSemantic proximity Read

Immunotherapy in Bladder Cancer: A Systematic Review of Clinical Trials and Therapeutic AdvancesSemantic proximity Read